Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Examining the impact of genetic testing for type 2 diabetes on health behaviors: study protocol for a randomized controlled trial.

Voils CI, Coffman CJ, Edelman D, Maciejewski ML, Grubber JM, Sadeghpour A, Cho A, McKenzie J, Blanpain F, Scheuner M, Sandelowski M, Gallagher MP, Ginsburg GS, Yancy WS Jr.

Trials. 2012 Aug 1;13:121. doi: 10.1186/1745-6215-13-121.

2.

Does Type 2 Diabetes Genetic Testing and Counseling Reduce Modifiable Risk Factors? A Randomized Controlled Trial of Veterans.

Voils CI, Coffman CJ, Grubber JM, Edelman D, Sadeghpour A, Maciejewski ML, Bolton J, Cho A, Ginsburg GS, Yancy WS Jr.

J Gen Intern Med. 2015 Nov;30(11):1591-8. doi: 10.1007/s11606-015-3315-5.

3.

Effect of genetic testing for risk of type 2 diabetes mellitus on health behaviors and outcomes: study rationale, development and design.

Cho AH, Killeya-Jones LA, O'Daniel JM, Kawamoto K, Gallagher P, Haga S, Lucas JE, Trujillo GM, Joy SV, Ginsburg GS.

BMC Health Serv Res. 2012 Jan 18;12:16. doi: 10.1186/1472-6963-12-16.

4.
5.

Design of a randomized trial of diabetes genetic risk testing to motivate behavior change: the Genetic Counseling/lifestyle Change (GC/LC) Study for Diabetes Prevention.

Grant RW, Meigs JB, Florez JC, Park ER, Green RC, Waxler JL, Delahanty LM, O'Brien KE.

Clin Trials. 2011 Oct;8(5):609-15. doi: 10.1177/1740774511414159.

7.

A randomized trial of the clinical utility of genetic testing for obesity: design and implementation considerations.

Wang C, Gordon ES, Stack CB, Liu CT, Norkunas T, Wawak L, Christman MF, Green RC, Bowen DJ.

Clin Trials. 2014 Feb;11(1):102-13. doi: 10.1177/1740774513508029.

8.

PRomotion Of Physical activity through structured Education with differing Levels of ongoing Support for people at high risk of type 2 diabetes (PROPELS): study protocol for a randomized controlled trial.

Yates T, Griffin S, Bodicoat DH, Brierly G, Dallosso H, Davies MJ, Eborall H, Edwardson C, Gillett M, Gray L, Hardeman W, Hill S, Morton K, Sutton S, Troughton J, Khunti K.

Trials. 2015 Jul 2;16:289. doi: 10.1186/s13063-015-0813-z.

9.
10.

DiAlert: a prevention program for overweight first degree relatives of type 2 diabetes patients: results of a pilot study to test feasibility and acceptability.

Heideman WH, de Wit M, Middelkoop BJ, Nierkens V, Stronks K, Verhoeff AP, Snoek FJ.

Trials. 2012 Sep 27;13:178. doi: 10.1186/1745-6215-13-178.

11.

Rationale and design: telephone-delivered behavioral skills interventions for Blacks with Type 2 diabetes.

Egede LE, Strom JL, Durkalski VL, Mauldin PD, Moran WP.

Trials. 2010 Mar 29;11:35. doi: 10.1186/1745-6215-11-35.

12.

Effect of communicating genetic and phenotypic risk for type 2 diabetes in combination with lifestyle advice on objectively measured physical activity: protocol of a randomised controlled trial.

Godino JG, van Sluijs EM, Marteau TM, Sutton S, Sharp SJ, Griffin SJ.

BMC Public Health. 2012 Jun 18;12:444. doi: 10.1186/1471-2458-12-444.

13.

Personalized genetic risk counseling to motivate diabetes prevention: a randomized trial.

Grant RW, O'Brien KE, Waxler JL, Vassy JL, Delahanty LM, Bissett LG, Green RC, Stember KG, Guiducci C, Park ER, Florez JC, Meigs JB.

Diabetes Care. 2013 Jan;36(1):13-9. doi: 10.2337/dc12-0884.

14.

The efficacy of a standardized questionnaire in facilitating personalized communication about problems encountered in cancer genetic counseling: design of a randomized controlled trial.

Eijzenga W, Aaronson NK, Kluijt I, Sidharta GN, Hahn DE, Ausems MG, Bleiker EM.

BMC Cancer. 2014 Jan 15;14:26. doi: 10.1186/1471-2407-14-26.

15.

Let's prevent diabetes: study protocol for a cluster randomised controlled trial of an educational intervention in a multi-ethnic UK population with screen detected impaired glucose regulation.

Gray LJ, Khunti K, Williams S, Goldby S, Troughton J, Yates T, Gray A, Davies MJ; Let's Prevent Collaborators..

Cardiovasc Diabetol. 2012 May 20;11:56.

16.

The MedSeq Project: a randomized trial of integrating whole genome sequencing into clinical medicine.

Vassy JL, Lautenbach DM, McLaughlin HM, Kong SW, Christensen KD, Krier J, Kohane IS, Feuerman LZ, Blumenthal-Barby J, Roberts JS, Lehmann LS, Ho CY, Ubel PA, MacRae CA, Seidman CE, Murray MF, McGuire AL, Rehm HL, Green RC; MedSeq Project..

Trials. 2014 Mar 20;15:85. doi: 10.1186/1745-6215-15-85.

17.

Tablet-Aided BehavioraL intervention EffecT on Self-management skills (TABLETS) for Diabetes.

Lynch CP, Williams JS, J Ruggiero K, G Knapp R, Egede LE.

Trials. 2016 Mar 22;17:157. doi: 10.1186/s13063-016-1243-2.

18.

Genetic counseling as a tool for type 2 diabetes prevention: a genetic counseling framework for common polygenetic disorders.

Waxler JL, O'Brien KE, Delahanty LM, Meigs JB, Florez JC, Park ER, Pober BR, Grant RW.

J Genet Couns. 2012 Oct;21(5):684-91.

19.

Health improvement and prevention study (HIPS) - evaluation of an intervention to prevent vascular disease in general practice.

Fanaian M, Laws RA, Passey M, McKenzie S, Wan Q, Davies GP, Lyle D, Harris MF.

BMC Fam Pract. 2010 Aug 5;11:57. doi: 10.1186/1471-2296-11-57.

20.

American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.

American Society of Clinical Oncology..

J Clin Oncol. 2003 Jun 15;21(12):2397-406.

PMID:
12692171

Supplemental Content

Support Center